Fanny Lacour - Concepedia

Author

Fanny Lacour

Institut Gustave Roussy

Also Known As

F LACOUR, F Lacour, FANNY LACOUR, Fanny Lacour

Publications

459

Citations

H-Index

Concepts

All Affiliations

Institut Gustave Roussy Institut Pasteur Institut de Biologie Physico-Chimique Centre National de la Recherche Scientifique

About

Fanny Lacour is an author at Institut Gustave Roussy specializing in medicine, cancer research, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	269
2	Immunology	5	5	129
3	Allergy	1	1	10
4	Biomolecular Engineering	1	1	30
5	Cell Biology	1	1	22

Fanny Lacour

Publications

380

Citations

H-Index

Page 1

	Year	Citations
<i>In vitro</i> study of cellular immunity against autochthonous human cancer Aneta Segall, O Weiler, Jean Génin, International Journal of Cancer	1972	85
ADJUVANT TREATMENT WITH POLYADENYLIC-POLYURIDYLIC ACID (POLYA.POLYU) IN OPERABLE BREAST CANCER J.‐P. Lacour, Alfred Spira, Jean‐Yves Petit, The Lancet Breast OncologyOncologyPolymer-drug ConjugateMedicineBreast Cancer	1980	83
Polyadenylic-polyuridylic acid, an adjunct to surgery in the treatment of spontaneous mammary tumors in C3H-He mice and transplantable melanoma in the hamster. Fanny Lacour, Alfred Spira, J.‐P. Lacour, PubMed Tumor BiologyMalignant DiseaseMedicineTumor GrowthMelanoma	1972	42
Reduced Incidence of Spontaneous Mammary Tumors in C3H/He Mice After Treatment with Polyadenylate-Polyuridylate Fanny Lacour, Geneviéve Lapprée Delage, Colette Chianale Science Tumor BiologyBreast OncologyC3h/he MicePolymer-drug ConjugateMedicine	1975	35
Enhancement of natural killer cell activity and 2-5A synthetase in operable breast cancer patients treated with polyadenylic; polyuridylic acid Ara G. Hovanessian, Jung Koo Youn, Claudine Buffet‐Janvresse, Cancer Mg PolyBreast OncologyImmunologyPharmacotherapyMetronomic Chemotherapy	1985	30
Enhancement of natural killer cell activity and 2-5A synthetase in mice treated with polyadenylic · polyuridylic acid Jung Koo Youn, Ara G. Hovanessian, Yves Rivière, Cellular Immunology PharmacologyImmunologyMedicine2-5A Synthetase	1983	27
Enhancement of Interferon-mediated Protein Kinase in Mouse and Human Plasma in Response to Treatment with Polyadenylic–Polyuridylic Acid (Poly A:Poly U) Ara G. Hovanessian, Yves Rivière, Luc Montagnier, Journal of Interferon Research	1982	26
Transplantable Malignant Tumors in Mice Induced by Preparations Containing Ribonucleic Acid Extracted From Human and Mouse Tumors<xref ref-type="fn" rid="FN1">2</xref> Fanny Lacour, J.‐P. Lacour, J Harel, JNCI Journal of the National Cancer Institute Tumor BiologyTransplantable Malignant TumorsTumoral PathologyMalignant DiseaseMice Induced	1960	22
Inhibition of C3H/He mouse mammary tumor growth by combined treatment with cyclophosphamide and polyadenylic-polyuridylic acid. Jung Koo Youn, Fanny Lacour, Gilbert Hue PubMed Chemoprevention StrategyImmunologyImmunoeditingPathologyMetronomic Chemotherapy	1982	20
Immunochemical study of anti poly I·poly C antibodies and of their reaction with RNA E. Nahon-Merlin, Liliane Moulart, Fanny Lacour Immunochemistry AllergyImmunologyAntibody ScreeningImmunochemistryAntibody Engineering	1973	10

Page 1